TY  -  
T1  - Prognostic markers in rectal neuroendocrine tumors 
SN  - 978-951-51-1629-1 /  
UR  - http://hdl.handle.net/10138/168966 
T3  -  
A1  - Jernman, Juha 
A2  -  
PB  -  
Y1  - 2015 
LA  - eng 
AB  - Neuroendocrine tumors of the rectum were regarded as benign, when Oberndorfer originally described the entity in 1907. Later, he acknowledged that some neuroendocrine tumors (or carcinoids, the term at that time) behave in a more aggressive manner, and a few of them even had the potential to metastasize with poor outcome. In the novel World Health Organization (WHO) classification launched in 2010, all neuroendocrine tumors of the gastrointestinal (GI) tract are malignant. In this classification... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Gastrointestinal Neoplasms; +classification; Neuroendocrine Tumors; +pathology; +secondary; Rectal Neoplasms; +diagnosis; +epidemiology; Intestinal Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms; Neoplasm Metastasis; Tumor Markers, Biological; Homeodomain Proteins; +metabolism; Tumor Suppressor Proteins; Antigens, Neoplasm; Stem Cells; Cyclin A; World Health Organization; Classification; Prognosis; Catastrophic Illness; Disease Progression; Neoplasm Grading; 3111 Biomedicine 
N1  -   
PP  -  
ER  -